Early-phase clinical trials in a pandemic: learning from the response to COVID-19.
Lancet Respir Med
; 10(7): 625-627, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35709826
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pandemics
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Lancet Respir Med
Year:
2022
Document type:
Article
Affiliation country:
Reino Unido